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The cellular phenotype is described by a complex network of molecular interactions. Elucidating network
properties that distinguish disease from the healthy cellular state is therefore of critical importance for
gaining systems-level insights into disease mechanisms and ultimately for developing improved therapies.
By integrating gene expression datawith a protein interaction networkwe here demonstrate that cancer cells
are characterised by an increase in network entropy. In addition, we formally demonstrate that gene
expression differences between normal and cancer tissue are anticorrelated with local network entropy
changes, thus providing a systemic link between gene expression changes at the nodes and their local
correlation patterns. In particular, we find that genes which drive cell-proliferation in cancer cells and which
often encode oncogenes are associated with reductions in network entropy. These findings may have
potential implications for identifying novel drug targets.
C
ancer cells differ from normal cells in terms of a complex landscape of genetic and epigenetic mutations
(more generally aberrations), which at a systems-level cause a fundamental dynamic rewiring of the
cellular interaction network, ultimately impairing normal cell physiology and allowing cells to acquire
key cancer hallmarks such as uncontrolled cell-proliferation and evasion of apoptosis1. Although a number of
studies have also made progress in identifying systems-level hallmarks underlying the cancer phenotype2,3, these
remain largely unexplored and many more hallmarks remain to be elucidated. Elucidating these cancer-system
principles represents a key challenge, not only for achieving a deeper understanding of cancer biology but also for
identifying novel drug targets4. Given that cellular function is governed by a complex network of cellular inter-
actions5, it seems natural to explore network properties which may help elucidate some of these cancer-system
hallmarks.
In this work, we explore the role of network entropy in cancer, with the weights reflecting correlations in gene
expression and normalized to define a random walk on a protein interaction network. While the concept of
entropy has been studied in the cancer context previously6–8, the current study is significantly different in that here
we consider a network entropy of a random walk on the graph, which was not considered in7,8. In our previous
study we explored this same network entropy but only in the context of metastatic breast cancer6. A secondary
motivation to focus on network entropy derives from a fluctuation theorem of dynamical systems theory9 which
asserts that the macroscopic resilience of a system, R, is correlated to the level of uncertainty or entropy
(disorder), S, of the underlying microsopic dynamical processes that take place within that system. More pre-
cisely, the theorem states that DSDRw0 where DR and DS represent respectively the changes to the robustness
and entropy of the system9,10. In11,12 this theorem was applied to protein interaction networks in yeast and
C.elegans, and it was demonstrated that those genes that contribute most to the network entropy are more likely
to be essential genes for the organism. This important result demonstrates that network entropy can predict a gene
property, i.e essentiality, which determines the system’s robustness under knock-down of the respective gene.
We point out that in the previous studies11,12, the stochastic matrix defining the dynamics on the network, and
hence the network entropy, was purely topological, i.e the stochastic matrix and entropy were completely
specified by the underlying network topology. In our goal to study the role of network entropy in cancer it is
key to compare to a normal reference, that is, cells of normal (healthy) physiology. Hence, in order to explore the
role of network entropy in cancer, we use static gene expression data from representative samples of normal and
cancer tissue to approximate a stochastic dynamics on a human protein interaction network. Thus, the dynamics
we consider refers to the random walk generated by a stochastic matrix on the network, and not to an underlying
temporal dynamics, as time course data for individual cancer patients is not available. To clarify, the stochastic
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matrix on the network is specified by the gene expression data and
therefore the dynamics is not entirely specified by the network topo-
logy. In fact, we assume that the network topology is unchanged
between the normal and cancer phenotypes, but allow the dynamics,
defining the weights in the network, to be dependent on the pheno-
type. Equivalently, we view the protein interaction network as pro-
viding only a backbone topological structure as to which interactions
are allowed, and use the phenotype-specific gene expression data
(and specifically, the correlations in gene expression over the disease
phenotype) to modulate and approximate the interaction probabil-
ities. Using this perspective, cancer cells differ from normal cells due
to differential weights on the same underlying network.
Therefore, our approach is based on two key concepts. First, the
integration of gene expression data with protein interaction net-
works to yield integrated weighted networks, a methodological
approach which has already proved fruitful in a variety of different
applications within the cancer genomics field6,7,13–25. Second, we use
the recent notion of ‘‘differential networks’’, which attempts to better
characterise disease phenotypes by studying the changes in the inter-
action patterns of these networks4,6,19,20,26,27, as opposed to merely
analysing the changes in mean levels of some molecular quantity
(e.g gene expression). As demonstrated by several studies6,19,20, dif-
ferential networks can identify important gene modules implicated
in cancer and also provide critical novel biological insights not
obtainable using other approaches. This differential network strategy
has recently received further impetus from studies of differential
epistasis mapping in yeast, demonstrating that differential interac-
tions may hold the key to understanding the systems-level responses
of cells to exogenous and endogenous perturbations, including those
present in cancer cells4,26.
Using network entropy defined locally for nodes in the network,
we here demonstrate that cancer is characterized by an increase in
network entropy. We next extend the notion of local entropy to a
non-local/global one, i.e for extended subnetworks, and find that
non-local entropy measures are less discriminatory of the cancer
phenotype. We also explore the relation between local differential
entropy and differential expression, and in the process, elucidate a
novel cancer system hallmark. Finally, we discuss the meaning of
our results in the context of the entropy-robustness theorem
above, and discuss the potential implications of our findings for
devising novel cancer therapies with a view to future studies that
will attempt to integrate drug sensitivity data with multi-dimen-
sional (mutational, copy-number, epigenetic and transcriptomic)
tumour profiles.
Results
We identified six expression data sets encompassing sufficient num-
bers of normal and cancer tissue samples and which passed our
quality control criteria (Methods). The tissues profiled were bladder,
lung, stomach, pancreas, cervix and liver. Integration of these
expression data sets with our protein interaction network (PIN)
(Methods) yielded sparse weighted networks of approximately
7500 nodes and 98500 edges. The average degree, median degree
and diameter of these integrated networks were approximately 26,
8 and 12, respectively. An important assumption underlying any
analysis on these integrated networks is that genes which are neigh-
bors in the network aremore likely to be correlated at the level of gene
expression. While this has been shown for specific data sets (see
e.g19), we verified that it also holds for the integrated mRNA-PIN
networks considered here (Fig. S1).
Increased local network entropy is a cancer system hallmark. We
previously showed that primary breast cancers that metastasize
exhibit an increased network entropy compared to breast cancers
that do not spread6. The network entropy of a node i was defined by6
Si~{
1
log ki
X
j[N ið Þ
pij log pij ð1Þ
where pij defines a stochastic matrix on the graph and ki is the degree
of gene i (see Methods).
Comparing distinct cancer phenotypes (e.g metastasizing cancers
to non-metastasizing) to each other has the advantage that large
sample collections are available, thus allowing for more reliable esti-
mates of expression correlations. However, having identified suitable
expression data sets encompassing relatively large and balanced
numbers of normal and cancer samples, we here sought to determine
if the network entropy also discriminates cancer from its respective
normal tissue phenotype. We first compared the local entropies
(equation 1) between normal and cancer, focusing on high-degree
nodes (here, nodes with at least 10 neighbours) following the
assumption that high degree nodes have higher relevance in cancer19.
Performing this comparison across six different tissue types, using
both unpaired and paired non-parametric statistics (to account for
the degree and hence node dependence of differential entropy)
clearly confirmed that cancer is characterised by an increased net-
work entropy (Fig. 1A, Table 1). Next, we sought to determine if this
increased network entropy is also seen if all nodes are included in the
analysis. The analogous analysis over all nodes of degree $ 2 (to
define the local entropy we need a node to have at least two neigh-
bours) confirmed that network entropy is increased in cancer (Fig.
S2), with the discriminatory power somewhat reduced but still highly
significant (Table 1).
We also observed that the magnitude of differential entropy
change was strongly anti-correlated to node degree (Fig. 2A). This
dependence of network entropy and differential network entropy on
the degree of the node was already explored by us previously and
reflects an intrinsic bias which needs to be corrected for ifmeaningful
rankings of genes are to be obtained6. In order to correct for this bias,
we here devised a statistical framework based on the jackknife to
derive z-statistics of differential entropy, which, by construction,
would be degree-independent (Methods). Confirming this, we
observed that absolute z-statistics did not exhibit a strong anti-cor-
relation with degree, and in fact were on the whole degree-independ-
ent (Fig. 2B). Supporting our previous result, we also observed that
differential entropy z-statistics were significantly higher in cancer
compared to normal tissue, independently of tissue type (Fig. 1B).
Non-local network entropy is increased in cancer, albeit weaker
than local network entropy. Next, we asked if the higher order
network entropy, computed over paths of length larger than 1, are
also discriminatory. To this end, we computed for the normal and
cancer phenotypes, a higher-order network entropy
S 2ð ÞN !{
X
ij
K 2ð Þij logK
2ð Þ
ij ð2Þ
where K 2ð Þij satisfies an approximate diffusion equation over the
network allowing for paths of maximum length 2 (Methods). We
point out that even when i and j are neighbors, that K 2ð Þij is not equal
to pij, since we allow for alternative signaling paths (of maximum
length 2) between genes i and j. Thus, this entropy also takes the well-
known redundancy of signaling paths into account28.
For S(2), we also observed a higher entropy in cancer compared to
normal tissue across all tissue types, although this increase was stat-
istically significant only for the four larger studies (Fig. 3). We also
computed higher order entropies up to paths of maximum length 5.
However, as with S(2), higher order network entropies S(k), k $ 3
generally exhibited reduced discriminatory power, suggesting that
the interesting changes associated with network entropy in cancer
are localised to neighbors and nearest neighbors in the interaction
network. This is not entirely surprising since we observed that
www.nature.com/scientificreports
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correlations in gene expression dropped significantly beyond neigh-
bours and second nearest neighbours (Fig. S3).
Differential network entropy and differential expression are anti-
correlated. We argued that if the observed changes in network
entropy have a biological basis, that there should be a relationship
between the changes in local entropy and gene expression. Speci-
fically, genes which become inactivated in cancer generally exhibit
lower expression and this should be reflected as an increased local
entropy around these nodes. Conversely, we hypothesized that genes
which become activated in cancer (i.e oncogenes), andwhich are thus
more likely to exhibit higher expression in cancer, would be asso-
ciated with a lower network entropy since the increased activity of
oncogenes is normally associated with activation of specific down-
stream signal transduction pathways. This means that there is less
uncertainty (i.e entropy) along which paths in the network the
information flow proceeds. To test this hypothesis, we computed
for each gene a regularized t-statistic29 that reflects the degree of
differential expression between normal and cancer tissue.
Similarly, for each gene we used the previous jackknife procedure
to obtain a z-statistic which is a statistical measure of the differential
entropy change between the normal and cancer phenotype (Me-
thods). Next, we selected those genes with significant changes in both
differential expression and differential entropy (P , 0.05). Re-
stricting to these genes, we first verified that differential entropy
Figure 1 | (A) Boxplots of the local network entropies (y-axis, S) (equation 1)in cancer (C) and normal (N) tissue for all nodes with degree$ 10 (, 3500
nodes) and across the six different tissue types. P-values are from a one-tailed unpairedWilcoxon rank sum test. Network entropies have been normalised
so that the maximum attainable value is 1. See Fig. S2 for the corresponding plot using all nodes with degree $ 2. (B) Boxplots of the
z-statistics of differential entropy between cancer and normal tissue. Positive z-statistics indicate higher entropy in cancer. P-values from a one-tailed
Wilcoxon rank sum test are given.
Table 1 | Wilcoxon rank sum test statistics comparing the local net-
work entropies (S) between normal and cancer, and across the six
tissue types. We provide statistics and P-values for the paired (i.e
treating the cancer and normal entropies for each gene as depend-
ent variables) Wilcoxon rank sum test. The test-statistics have been
normalised to lie between 0 and 1, and thus correspond to an AUC
(Area Under receiver operating Curve). AUC values close to 0.5
mean no discrimination, while AUC values closer to 1 indicate a
highly significant discrimination between normal and cancer. The
corresponding P-values assess the significance of the deviation
from 0.5 under a one-tailed test, so that it specifically measures
significance of higher entropy in cancer. The top two rows represent
the statistics when considering nodes of degree $ 10, while the
bottom rows correspond to all nodes for which the entropy can
be defined, i.e nodes of degree $ 2
BLAD. LUNG GAST. PANC. CERV. LIV.
k $ 10
AUC 0.75 0.92 0.69 0.97 0.88 0.88
P , 10250 , 10250 , 10250 , 10250 , 10250 , 10250
k $ 2
AUC 0.76 0.84 0.69 0.89 0.78 0.77
P , 10250 , 10250 , 10250 , 10250 , 10250 , 10250
www.nature.com/scientificreports
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statistics were not correlated with degree or at least only marginally
so (Table 2). In contrast, differential entropy statistics exhibited a
strong anti-correlation with differential expression independently of
tissue type, and these anti-correlations remained significant after
adjustment for node degree (Table 2). To assess the overall signifi-
cance of a composite null hypothesis test of no association between
differential expression and differential entropy, we used Fisher’s
combined probability test30 to obtain an overall P-value (P 5
8e227), which was highly significant (Table 2). Confirming this
analysis further, we observed that genes significantly overexpressed
in cancer showed preferential reductions in network entropy com-
pared to genes which were underexpressed, and the associated odds
ratios (OR) were statistically significant across all 6 tissue types
(Table 3). Once again, treating the 6 data sets as independent tests,
Fisher’s combined probability test confirmed the overall significance
(P 5 1e211) of the 6 P-values in (Table 3). Thus, the results in
Tables 2 and 3 are consistent with each other, supporting the exist-
ence of another cancer system hallmark: that differential expression
and differential network entropy are anticorrelated.
Cell-cycle/proliferation genes preferentially associate with a lower
network entropy in cancer. Overexpression of cell-cycle and cell-
proliferation genes is a key cancer hallmark withmany of these genes
representing also candidate drug targets1. Althoughwe have seen that
differential entropy changes anti-correlate with differential expres-
sion, it is important to check if (1) cell-cycle/proliferation genes are
preferentially associated with a reduced network entropy, and (2)
whether the anti-correlation between differential entropy and diffe-
rential expression is driven entirely by cell-cycle genes. To address
the first point, we performed a gene set enrichment analysis (GSEA)
using the Molecular Signatures Database (MSigDB31) on the top
ranked genes, ranked according to the statistics of differential net-
work entropy (separately for increased and reduced entropy). The
GSEA analysis showed that genes implicated in the cell-cycle were
indeed strongly enriched among genes exhibiting lower network
entropy in cancer, but not so among genes exhibiting increases in
network entropy (Table 4).
To address the second point, we repeated the correlation analysis
between differential entropy and differential expression, but remov-
ing cell-cycle genes prior to the analysis. Importantly, we still
observed the anti-correlation between differential entropy and dif-
ferential expression in 5 of the 6 tissue types (Table S1), indicating
that this anticorrelation is a general systemic feature.
It could be argued that since tumour expression profiles analyzed
here are from the bulk, meaning that the measured expression pro-
files represent an average over epithelial tumour cells and non-
epithelial stromal cells (e.g immune cells), that entropy changes are
entirely confounded by changes in the tumour-stromal cell composi-
tion ratio. Therefore, it is important to point out here that the enrich-
ment of cell-cycle/proliferation genes among those showing the
Figure 2 | (A) Scatterplots of absolute differential network entropy changes between normal and cancer (y-axis) against log2(k) (x-axis) where k is the
degree of the node, for each tissue type. (B) Scatterplots of the corresponding absolute differential entropy z-statistics (y-axis) against log2(k) (x-axis). In
both cases, we provide the Spearman rank correlation coefficient (SCC).
Figure 3 | z-statistics of differential non-local network entropy (x-axis)
for the six different tissues (y-axis). The network entropy considered here
is the S 2ð ÞN measure (equation 2) which is defined for a stochastic diffusion
matrix for maximum path lengths of order 2 (Methods). Positive z-
statistics means higher entropy in cancer compared to normal. Green lines
indicate the 95% confidence interval envelope and given P-values are from
a normal null distribution centred at zero.
www.nature.com/scientificreports
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largest reductions in network entropy, indicates that these differ-
ential entropy changes reflect underlying changes in the epithelial
tumour cell population, and not changes in the tumour-stromal cell
ratio. In other words, the fact that entropy changes can retrieve
known tumour cell biology (i.e increased proliferation of tumour
cells) shows that interesting tumour cell biology can be extracted
from the network entropy.
Discussion
In this work we have constructed a weighted network entropy and
have shown that it is increased in cancer compared to normal tissue.
Both local and non-local versions of the network entropy were con-
sidered, with the local entropy exhibiting the more significant
increases. This partly reflects the local nature of expression correla-
tions in the protein interaction network with correlations dropping
significantly beyond neighbours and second nearest neighbours. It is
of importance to discuss (i) whatmay cause cancer cells to exhibit the
observed increase in network entropy and (ii) what it may mean for
the cancer phenotype itself.
Concerning the first question, one would expect genes that
become inactivated in cancer to represent foci of increased network
entropy since the inactivation compromises its biological function: at
the level of mRNA expression this would manifest itself as reduced
expression correlations with its interacting neighbors, but more gen-
erally as an increased uncertainty as to which neighbors it may inter-
act with. Conversely, for a gene that is overactivated in cancer its
biological function is enhanced, thus confering the cell a selective
advantage, which for oncogenes manifests itself as an increased flux
of the associated oncogenic pathway. In terms of the local network
entropy this increased flux along a particular pathway in the network
corresponds to a reduced uncertainty (i.e less network entropy) along
which path the information is transferred. In line with these bio-
logical expectations we did observe that genes overexpressed in can-
cer were significantly more likely to exhibit reductions in network
entropy than underexpressed genes. Thus, the fact that cancers were
characterised globally by an increased network entropy points
towards a higher frequency of inactivating over activating alterations
in cancer. Intuitively, this makes sense since a random mutation/
alteration is more likely to inactivate than activate a gene, and indeed
this would be in agreement with recent reports suggesting that most
genetic alterations are inactivating and affect tumour suppressors32.
We should point out that to formally demonstrate that the increased
network entropy is associated with an increased frequency of inac-
tivating alterations (mutations, losses and deletions, promoter DNA
methylation) in the tumours analysed here is not possible asmatched
mutational, copy-number and DNA methylation information is not
available for these specific tumours. However, it will be interesting to
explore this in the context of the matched multi-dimensional cancer
genomic data from the The Cancer Genome Atlas (TCGA)33.
Concerning the second question posed above, our observation that
differential network entropy and differential expression are anti-
correlated is strongly suggestive of an underlying entropy robustness
theorem, DSDR.0. In fact, we have seen that genes driving cell-
proliferation, which are known to be overexpressed in cancer34 and
which often encode oncogenes1, were preferentially associated with
significant reductions in network entropy. Now, it is well known that
cancer cells exhibit the phenomenon of oncogene addiction, whereby
they become overly dependent and reliant on activated oncogenes1.
Oncogene addiction has been exploited therapeutically: indeed, in
cases where the oncogene is druggable, targeting of the oncogene has
proved to be an effective drug therapy strategy1. Thus, oncogenes
have the paradoxical effect of making cancer cells less robust to
targeted intervention. Hence, our observation that overexpressed
genes, and oncogenes in particular, are associated with reductions
in network entropy is consistent with an entropy-robustness the-
orem like equation 1. Similarly, the observed increased network
Table 3 | Relation between differential expression and differential
entropy. The odds ratio (OR) reflects the odds of a gene overex-
pressed in cancer showing reduced network entropy in cancer,
compared to a gene that is underexpressed. The P-value (P) reflects
the statistical significance of the odds ratio. The last row gives the P-
value of Fisher’s combined probability test assessing the overall
significance of the 6 independent P-values
BLAD. LUNG GAST. PANC. CERV. LIV.
OR 6.24 3.07 2.43 2.17 3.64 2.80
P 3e29 0.04 0.05 0.03 0.02 0.005
Fisher-P 1e211
Table 4 | Enrichment analysis of cell-cycle genes among the top
10% ranked genes exhibiting entropy increases (C.N) and
decreases (N.C) in cancer (C) compared to normal (N) tissue.
The enrichment odds ratio (OR) and P-value (P) is from a one-tailed
Fisher’s exact test. NA5not available due to insufficient number of
genes among the top 10%
BLAD. LUNG GAST. PANC. CERV. LIV.
S(N.C)
OR 3.92 6.07 1.35 NA 2.62 6.61
P 2e28 0.07 0.17 NA 0.04 4e211
S(C.N)
OR 0.44 0.72 1.13 0.50 1.04 0.50
P 0.99 0.93 0.36 0.99 0.46 0.99
Table 2 | We provide the Pearson Correlation Coefficient (PCC) and P-value (P) between the differential entropy z-statistics z(dS), and the
node degree k (top two rows), between the differential entropy z-statistics and the t-statistic of differential expression t(dE) (middle two
rows) and finally also the Partial Correlation Coefficient and P-value between z(dS) and t(dE) after adjustment for k (two second last rows).
The last row gives the P-value of Fisher’s combined probability test assessing the overall significance of the 6 independent P-values
BLAD. LUNG GAST. PANC. CERV. LIV.
z(dS) , k
PCC 0.02 0.08 0.15 0.07 0.09 0.03
P 0.76 0.06 0.09 0.02 0.22 0.72
z(dS) , t(dE)
PCC 20.48 20.12 20.21 20.14 20.23 20.29
P 8e213 0.005 0.02 1e26 0.001 6e25
z(dS) , t(dE) |k
PCC 20.49 20.14 20.23 20.15 20.23 20.29
P 6e215 0.001 0.009 3e27 7e24 3e25
Fisher-P 8e227
www.nature.com/scientificreports
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entropy in cancer could underpin the intrinsic robustness of cancer
cells to general endogenous and exogeneous perturbations, including
those caused by environmental stresses (e.g hypoxia) within the
tumour microenvironment1.
It follows from the above argument that network entropy may be
used to identify novel drug targets. As a specific example, we
observed that the kinase AURKB exhibited the largest reductions
in network entropy in bladder cancer (Table S2). Importantly,
AURKA, which has already a well established oncogenic role in blad-
der cancer (see e.g35) was also highly ranked (Table S2). Thus, our
analysis suggests that the closely related kinase, AURKB, which has
already been implicated as an oncogene and potential drug target in
other cancers36–38, may also play an equally important role in the
pathogenesis of bladder cancer. In fact, a very recent study further
showed that AURKB phosphorylates and instigates degradation of
P5339, a key tumour suppressor in cancer. Given that AURKB is also
druggable (by the drug rebamipide)40, this kinase therefore repre-
sents an attractive drug target for those bladder cancers that over-
express it. In cases where the oncogene is not directly druggable, we
speculate that differential network entropy may be used to identify
neighboring druggable targets that also exhibit significant reductions
in network entropy. This novel computational strategy could there-
fore guide non-oncogene addiction based therapeutic strategies that
aim to select drug targets within the same oncogenic pathway41,42.
Moreover, it has become clear that mutational and copy-number
status alone or in combination with gene expression levels are not
highly predictive of drug response43,44, hence there is an urgent need
for improved in-silico predictors of drug sensitivity. We leave these
open and exciting questions for a future bioinformatic study that will
analyze matched genomic (mutational, copy-number), epigenomic
(DNA methylation), functional (e.g mRNA expression) and drug
sensitivity data for large panels of drugs and cancer cell-lines43,44.
While network entropy provided a good discrimination between
normal and cancer tissue, it is clear that it does not outperform raw
gene expression levels, which offer significantly higher classification
accuracies34. Other network measures may also provide equally good
discriminators of the cancer phenotype as network entropy. Indeed,
the average of the absolute correlations over neighbours of a given
node provides an equally good discriminator (Fig. S4), indicating
that the loss of local connectivity is a key cancer characteristic.
However, the loss of local connectivity (i.e reduced absolute correla-
tions) does correspond to an increase in local network entropy.
Therefore, network entropy may provide, through an entropy-
robustness theorem (equation 1) a more meaningful framework in
which to interpret and understand the systemic changes in gene
expression between normal and cancer tissue.
In summary, in this work we have explored the notion of network
entropy in cancer and have used it to elucidate two cancer system
hallmarks: (1) that network entropy is increased in cancer relative to
the normal phenotype, and (2) that differential network entropy is
anti-correlated with differential expression. Therefore, this work fur-
ther supports the view that the cell’s network entropy and robustness
are correlated. Further investigation of the statistical mechanical
principles characterising cancer gene networks is warranted as this
may help rationalize the choice of drug targets.
Methods
The protein interaction network (PIN). We downloaded the complete human
protein interaction network from Pathway Commons (www.pathwaycommons.org)
(Jan.2011)45, which brings together protein interactions from several distinct sources.
We then built a reduced protein interaction network from integrating the following
sources: the Human Protein Reference Database (HPRD)46, the National Cancer
Institute Nature Pathway Interaction Database (NCI-PID) (pid.nci.nih.gov), the
Interactome (Intact) http://www.ebi.ac.uk/intact/ and the Molecular Interaction
Database (MINT) http://mint.bio.uniroma2.it/mint/. Protein interactions in this
network include physical stable interactions such as those defining protein
complexes, as well as transient interactions such as posttranslational modifications
and enzymatic reactions found in signal transduction pathways, including 20 highly
curated immune and cancer signaling pathways from NetPath (www.netpath.org)47.
We focused on non-redundant interactions, only included nodes with an Entrez gene
ID annotation and focused on the maximally conntected component, resulting in a
connected network of 10,720 nodes (unique Entrez IDs) and 152,889 documented
interactions. In what follows we refer to this network as the ‘‘PIN’’.
Normal and cancer tissue gene expression data sets. We searched Oncomine34 for
studies which (i) had profiled reasonable numbers of cancer and normal tissue
samples (at least, 25 of each type), and (ii) which had been profiled on an Affymetrix
platform. In order to reliably estimate covariance of two genes across a set of samples,
at least , 25 samples are needed. The second criterion reflects the desire to conduct
the study on a common platform and Affymetrix arrays are the most widely used.
Using the same platform across studies ensured that the integrated mRNA-PIN
networks were of similar size. In all cases, the intra-array normalised data was
downloaded from GEO (www.ncbi.nlm.nih.gov/geo/), quantile normalized, and
subsequently probes mapping to the same Entrez gene ID were averaged. We then
subjected each study that passed these criteria through a quality control step, which
involved a Principal Component Analysis (PCA) to check that (iii) the dominant
component of variation correlated with cancer/normal status. If not, this indicated to
us a more pronounced source of non-biological variation, which would confound our
downstream analysis. There were six studies satisfying all three criteria and the tissues
profiled included bladder (48 normals and 81 cancers)48, lung (49 normals and 58
cancers)49, gastric (31 normals and 38 cancers)50, pancreas (39 normals and cancers)51,
cervix (24 normals and 33 cancers52 and liver (23 normals and 35 cancers)53.
Integrated PIN-mRNA expression networks and the stochastic matrix. For a given
cellular phenotype (i.e. cancer or normal), we build an integrated mRNA-PIN using
the same procedure as described in6. Briefly, edge weights in the PIN are defined by a
stochastic matrix pij,
pij~
wijP
k[N ið Þ wik
ð3Þ
with
P
j[N ið Þ pij~1, whereN ið Þ denotes the neighbors of gene i in the PIN and where
wij~
1
2
1zCij
 
denotes the transformed Pearson correlation coefficient Cij of gene
expression between genes i and j across the samples belonging to the given phenotype.
This definition of wij reflects our desire to treat correlations and anti-correlations
differently. We also note that we enforce pij5 0 whenever (i, j) is not an edge in the
PIN. Thus, the integrated mRNA-PINs with the edge weights as defined by pij, can be
viewed as approximate models of signal transduction flow (as measured by positive
gene-gene correlations in expression) subject to the structural constraint of the PIN.
Applying this procedure to the two phenotypes yields two integrated PIN-mRNA
networks, one for the cancer phenotype with stochastic matrix p Cð Þij , and one for the
normal phenotype with stochastic matrix p Nð Þij . It is important to point out that the
construction of our stochastic matrix means that the topological degrees of each node
remain unchanged between the normal and cancer phenotypes: it is only the weights
specifying the randomwalk on the network which differ between the two phenotypes.
It is important to stress that we have approximated signal transduction flux on the
PIN by positive correlations in expression between interacting genes. This is
obviously a crude approximation and therefore a limitation of this study, however,
until other types of matched molecular data (e.g protein expression, phosphorylation
and other post-translational modification states) become available on a genome-wide
basis, we are restricted to the use of only gene expression data. Some further jus-
tification for the use of gene expression correlations to approximate signaling flux
over the network will be provided by careful comparison of the local correlations to
those which are non-local.
A heat kernel stochastic matrix. It is clear that the stochastic matrix pij above defines
a (biased) randomwalk on the networkN . Onemay thus compute an information (or
probability) flux between any two nodes i and j in N 54. In fact, it is clear that the
probability flux ofmoving from i to j over a path of length L is given by (pL)ij. It follows
that the total probability flux Eij between i and j is given by
Eij~c
X?
L~1
aL p
L
 
ij ð4Þ
where c is a normalisation factor and where we have introduced a set of arbitrary
weights aL to allow variable contributions for paths of different lengths. One
possibility is to suppress paths of longer lengths using aL 5 1/L!, which also
guarantees convergence of the infinite series54. Formally, defining aL 5 tL/L!, we
obtain the stochastic matrix
Kij tð Þ~
P?
L~1
tL
L! p
Lð Þij
et{1
ð5Þ
where we have introduced a ‘‘temperature’’ parameter t55. This stochastic matrix is a
modified version of the heat-kernel stochastic matrix55 and satisfies
LtK tð Þ~{K tð Þ I{pð Þz p{K tð Þet{1 ð6Þ
where we have suppressed matrix indices and where I denotes the identity matrix.
Since pij, Kij(t) # 1 for all i, j, t, it follows that for sufficiently large temperatures
(t $ 1), K(t) approximates a solution of the heat-diffusion equation55
www.nature.com/scientificreports
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LtK tð Þ<{K tð Þ I{pð Þ ð7Þ
Thus, the choice a 5 tL/L! leads to a natural interpretation in terms of a discrete
approximate diffusion process on a graph56. This construction is therefore closely
related to the heat kernel PageRank algorithm55–57.
The network entropy.Given the matrix Kij, letQ denote the number of non-zero Kij,
i.e Q 5 Sij I(Kij . 0) where I is here the indicator function. We then define the
network entropy as
SN tð Þ~{
1
logQ
X
ij
Kij tð Þ logKij tð Þ ð8Þ
where we have rescaledKij(t) by 1/n in order to ensure thatSij Kij(t)5 1. Note that the
entropy defined above can be thought of as a non-equilibrium entropy, since the
stationary distribution pi ofKij, defined by piKij5 pj , was not included. Our choice to
consider this non-equilibrium version is motivated by our desire to avoid biasing the
entropic contribution of each node to its topological properties (e.g degree).
Suppose now that we consider diffusion/flux over paths of maximum length 1.
Then, this leads to Kij5 pij/n where n is the number of nodes inN (we have set t5 1
for convenience). This leads to the expression
S 1ð ÞN ~
1
logQ
{
1
n
X
ij
pij log pijz log n
( )
~
1
logQ
1
n
X
i
Si log kiz log n
( )
In the above expression, Si is the local entropy of node i6,56,
Si~{
1
log ki
X
j[N ið Þ
pij log pij ð9Þ
where ki is the degree of node i and the normalisation factor ensures that the max-
imum attainable entropy is equal to 1, independent of the degree of the node.We note
that S 1ð ÞN is in effect a network average of these local network entropies, but is distinct
from the global entropy defined in equation 8.
Next, we can consider flux over paths up to length two, in which case
K 2ð Þij ~
pijz
1
2 p
2ð Þij
3
2n
ð10Þ
and the corresponding entropy,
S 2ð ÞN ~{
1
logQ
X
ij
K 2ð Þij logK
2ð Þ
ij ð11Þ
In principle, we can estimate the entropy S(h) for paths of arbitrary order h. In this case,
K hð Þij ~
1
n
Ph
r~1
1
r!
Xh
r~1
1
r!
prð Þij
 !
ð12Þ
In this work we compute network entropies up to moments of order 5 using the R-
package expm. Not going beyond h 5 5 is justified for two reasons: (i) the most
interesting behaviour is found for h # 3, (ii) the computational cost for h 5 5 is
considerable, for instance, estimation of network entropy and associated sampling
variance estimates for a typical data set of 30 samples and, 7500 nodes at h5 5 takes
at least , 20 hours on a high-performance quad processor workstation.
Sampling variance using the jackknife. To estimate the statistical significance of
observed differences in entropy between two phenotypes, we decided to use the
jackknife procedure58. Briefly, the jackknife procedure removes one sample at a time
from the given phenotype and recomputes the desired quantity S (here entropy).
Thus, if there are n samples in the given phenotype one obtains n jackknife estimates
(S^J,j : j~1, . . . ,n). A jackknife estimate for the mean Sm and variance SV of S is then
obtained as
S^m~nS^{ n{1ð Þ S^J,j
 
j
S^V~
n{1
n
Xn
j~1
S^J,j{ S^J,j
 
j
 2
where S^ is the estimate using all n samples and S^J,j
 
j~
1
n
Pn
j~1 S^J,j . Thus, for two
phenotypes ‘‘N’’ and ‘‘C’’, we compute the difference DSJ~S^ Cð Þm {S^
Nð Þ
m and obtain a z-
statistic
z~
DSJ
sJ
ð13Þ
where sJ~
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
S Nð ÞV zS
Cð Þ
V
q
.
This jackknife procedure can be applied to the network entropy defined over the
network or for each node individually. Note that in the case where we obtain
z-statistics for each gene/node, the genes can then be ranked according to the sig-
nificance of this z-statistic. We also note that by construction the z-statistic should be
independent of the degree of the node. In fact, while both the differential entropy DSJ
as well as the standard deviation estimate sJ will demonstrate the same degree-
dependence, the ratio given by the z-statistic z 5 DSJ (k)/sJ(k) should be degree
independent. We demonstrate this empirically across the six different data sets
considered here.
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